Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $165.00K in the quarter ending September 30, 2024, with 17.02% growth. This brings the company's revenue in the last twelve months to $688.00K, up 49.57% year-over-year. In the year 2023, Cardiff Oncology had annual revenue of $488.00K with 26.42% growth.

• Revenue (ttm): $688.00K
• Revenue Growth: +49.57%
• P/S Ratio: 166.46
• Revenue / Employee: $21,500
• Employees: 32
• Market Cap: 129.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	488.00K	102.00K	26.42%
Dec 31, 2022	386.00K	27.00K	7.52%
Dec 31, 2021	359.00K	-7.00K	-1.91%
Dec 31, 2020	366.00K	121.37K	49.61%
Dec 31, 2019	244.63K	-133.69K	-35.34%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.